Fig. 1: Hurdles and technological barriers for CM commercialization. | Nature Communications

Fig. 1: Hurdles and technological barriers for CM commercialization.

From: Dynamically cultured, differentiated bovine adipose-derived stem cell spheroids as building blocks for biofabricating cultured fat

Fig. 1

a Product development pathways for CM showing the technological, financial, consumer, and regulatory gaps that need to be addressed for successful CM commercialization. b Schematic overview of the work process in relation to the product development pathways for CM. First, creation of a one-step differentiation protocol without the use of antibiotics and then the establishment of static and dynamic primary bASC spheroids. This is followed by the characterization, bioprinting and fatty acid analysis of the spheroids.

Back to article page